In early June 2026, Cyber Robotic Solutions, a company linked to León Manuel Bartlett Álvarez—the son of former CFE director Manuel Bartlett Díaz—secured two direct-award contracts from prominent Mexican health institutions totaling more than 35 million pesos. These deals, announced between June 4 and June 11, highlight a longstanding pattern of government procurement favoring this firm, which has been a key player in public health services throughout recent administrations.

The first contract, dated June 4, 2026, was awarded by the National Cancer Institute (INCan) for robotic surgery services targeting cancers of the colon, rectum, thorax, gynecological, and urological areas. Valued at approximately 7.7 million pesos (including VAT), the contract runs from June 5 to December 31, 2026. The official notification was signed by Gustavo González Porcayo, INCan’s Deputy Director of Material Resources.

A week later, on June 11, 2026, the Hospital Juárez de México (HJM) granted a multi-year contract for preventive and corrective maintenance of the Radixact helical linear accelerator and peripheral equipment. This contract covers 2026 and 2027, with a combined value exceeding 27.7 million pesos. The award was formalized during the hospital’s 5th Extraordinary Acquisition Committee session of 2026 and signed by Emilio Morales Tirado, head of the Procurement Department.

Together, these contracts represent a significant public investment in advanced medical technology and maintenance services, reinforcing Cyber Robotic Solutions’ role as a recurring supplier in Mexico’s federal health sector.

While both contracts comply with the Public Sector Acquisitions Law and were approved through proper channels, the continuity of this company’s involvement raises questions about procurement patterns. Cyber Robotic Solutions has been identified by Mexican anti-corruption groups as owned by León Manuel Bartlett Álvarez and has amassed hundreds of millions of pesos in government contracts over the past decade.

During the administration of Andrés Manuel López Obrador, the company experienced what some media described as a “golden period,” securing 49 contracts worth over 509 million pesos, mostly through direct awards. In 2024 alone, it signed 15 contracts with agencies including Sedena, IMSS, ISSSTE, the Navy, and INCan, totaling 181 million pesos. The Hospital Juárez de México has been a consistent client, awarding a similar maintenance contract for the Radixact equipment in 2024 valued at over 29 million pesos.

Despite a history of sanctions—including two suspensions totaling over four years and fines exceeding two million pesos imposed by the Secretariat of Public Function in 2020—the company has continued to operate. Notably, a 2020 administrative tribunal granted a precautionary measure lifting a 21-month suspension, allowing Cyber Robotic Solutions to participate in federal contracts while legal proceedings were ongoing.

The timing of these June 2026 contracts coincides with Mexico’s hosting of the FIFA World Cup, a period marked by heightened government spending and visibility. Although the contracts are unrelated to the tournament, their announcement during this moment of national attention underscores the ongoing role of this firm in public health infrastructure.

Requests for comment were sent to the National Cancer Institute, Hospital Juárez de México, and Cyber Robotic Solutions; responses are pending.

For migrants and international residents in Mexico, understanding these procurement dynamics offers insight into how public resources are allocated in health services—a sector critical to social equity and access. The continued investment in robotic surgery and advanced medical equipment maintenance reflects a commitment to modernizing healthcare, even as transparency and accountability remain vital concerns.